Dexin China Remains in Liquidation with Trading Suspended and No Restructuring Deal Reached

Reuters12-16 16:32
<a href="https://laohu8.com/S/02019">Dexin China</a> Remains in Liquidation with Trading Suspended and No Restructuring Deal Reached

Dexin China Holdings Company Ltd., currently in liquidation, has announced that as of the latest update, it has not entered into any legally binding agreement or material commitment regarding a potential restructuring. The company has also changed its share registrar, with Computershare Hong Kong Investor Services Limited ceasing its role effective 30 June 2024. Trading in the company's shares remains suspended, and the liquidators continue to seek a suitable replacement registrar while providing periodic updates to shareholders on the resumption progress.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexin China Holdings Company Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251216-11956777), on December 16, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment